Monteloeder, a subsidiary of SUANNUTRA, has secured regulatory approval for its RelaxPLX ingredient — a lemon verbena extract. As part of this development, the company received an individual license from South Korea's Ministry of Food and Drug Safety for its extract's sleep quality support claim, as well as a Health Canada Product License that authorizes multiple claims related to both sleep improvement and stress reduction. This includes the temporary relief of perceived stress and the reduction of cortisol as a physical stress biomarker.
Monteloeder's lemon verbena extract formulation is supported by three randomized, placebo-controlled clinical trials, which were conducted across different demographics — from adults with sleep disturbances and stressed adults to adolescents experiencing mild sleep and stress challenges. The studies utilized a combination of validated questionnaires, objective sleep assessments, and physiological markers to substantiate the ingredient's efficacy.
Image Credit: Monteloeder
Why This Trend Is Growing
- Clinically Validated Botanicals
- Randomized trial-backed plant extracts are creating room for differentiated wellness products that compete on measurable sleep, stress, and biomarker outcomes.
- Regulated Sleep Claims
- Government-authorized health claims are elevating consumer trust in natural sleep aids while opening premium positioning for brands with defensible efficacy data.
- Stress Biomarker Wellness
- Cortisol-linked formulations signal a shift toward quantified stress support, where natural ingredients can bridge emotional wellbeing and physiological validation.
Industries Being Reshaped
- Nutraceuticals
- Supplement manufacturers are gaining new pathways to develop science-led sleep and relaxation products with stronger regulatory credibility.
- Functional Foods
- Clinically supported lemon verbena ingredients can expand fortified snacks, teas, and beverages into evidence-based stress and sleep support formats.
- Digital Health
- Sleep tracking platforms and wellness apps have potential alignment with validated ingredient interventions that connect subjective recovery with objective sleep data.
